Clinical Trials
47 trialsPROCAN-B+
University of Sunderland
Investigating the Safety and Diagnostic Performance of 68Ga-NYM032 Injection PET/CT in Men With Newly Diagnosed Prostate Cancer.
Norroy Bioscience Co., LTD
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer
National Institutes of Health Clinical Center (CC)
Multimodal Imaging and Digital Pathology for Prostate Cancer Prediction
Guangxi Medical University
Noninvasive Urine Testing for Urothelial Carcinoma
Henan Provincial People's Hospital
TENS 2
Medical University of Gdansk
Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis
Peking University First Hospital
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
NYU Langone Health
High Cardiovascular Risk Intervention With Cardio-Oncology Consultation for Prostate Cancer Following Androgen Receptor Pathway Inhibitor (ARPI) Therapy (Heart-Safe)
Cedars-Sinai Medical Center
Theranostic Applications of Radionuclides in Prostate Cancer
Guilin Medical University, China
EXO-MET
Xijing Hospital
The Enhancement of Diagnostic and Grading Efficacy of Prostate Cancer by New MRI Sequences: A Prospective Observational Study Based on New MRI Sequences in a Single Center
The First Affiliated Hospital of Soochow University
CLIQQC
Société Algérienne de Formation et Recherche en Oncologie
DEPICT
Xijing Hospital
PPSARP
Lithuanian University of Health Sciences
LUTACT
University of California, San Francisco
Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer
Duke University
INSIGHT-PCa
Asan Medical Center
Archival of Human Biological Samples in CU-Med Biobank
Chinese University of Hong Kong
Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis
Peking University First Hospital
MUSIC-PRT
Dokuz Eylul University
PROSTest_STRAT
Wren Laboratories LLC
Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Turkish Version of the UCLA Prostate Cancer Index
Lokman Hekim University
CLEAR-PC
Universidad Miguel Hernandez de Elche
REMRI
University of Eastern Finland
EBNK-ST-001
Essen Biotech
PSMA PET for Surveillance After Focal Therapy
University of Chicago
ADHERE
Royal Marsden NHS Foundation Trust
Upright MRI for Prostate Cancer Screening
Icahn School of Medicine at Mount Sinai
COSMO
Harvard Medical School (HMS and HSDM)
Castration With Abiraterone 250 mg Without LHRH Analogs or Blockers in Patients With Prostate Cancer Requiring Hormonal Intensification (Multicenter Phase 2)
SMED Clinical Research
Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe
Johns Hopkins University
Virtual Biopsy of Prostate Cancer Using PSMA PET and AI
University Hospital of North Norway
exo-PRECISE
Xijing Hospital
NMIBC
Xijing Hospital
Application of Quantum Detection-Driven Artificial Intelligence Algorithms for Single-Molecule cfDNA Characterization in the Early Diagnosis of Prostate Cancer
Shanghai Changzheng Hospital
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
University of Erlangen-Nürnberg Medical School
Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots
AdventHealth
FOCUS-PC
Albany Medical College
Spotlight
Blue Earth Diagnostics
PREPP
Odense University Hospital
HOPE
Institut Curie
PREDICT
Gold Standard Phantoms
URODX-FGFR3
Institut de Cancérologie de Lorraine
(3D) Ultrasound Imaging Liver and Kidney
Western University, Canada
Comparison of MRI Artificial Intelligence-guided cTB Versus Routine cTB in Prostate Cancer Diagnosis
Peking University First Hospital